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Neck lymph node status is the most important factor for prognosis in head and neck squamous cell carcinoma. Sentinel node
detection reliably predicts the lymph node status in melanoma and breast cancer patients. This study evaluates the predictive
value of sentinel node detection in 50 patients suffering from pharyngeal and laryngeal carcinomas with a N0 neck as assessed
by ultrasound imaging. Following 99m-Technetium nanocolloid injection in the perimeter of the tumour intraoperative sentinel
node detection was performed during lymph node dissection. Postoperatively the histological results of the sentinel nodes
were compared with the excised neck dissection specimen. Identiﬁcation of sentinel nodes was successful in all 50 patients
with a sensitivity of 89%. In eight cases the sentinel node showed nodal disease (pN1). In 41 patients the sentinel node was
tumour negative reﬂecting the correct neck lymph node status (pN0). We observed one false-negative result. In this case the
sentinel node was free of tumour, whereas a neighbouring lymph node contained a lymph node metastasis (pN1). Although
we have shown, that skipping of nodal basins can occur, this technique still reliably identiﬁes the sentinel nodes of patients with
squamous cell carcinoma of the pharynx and larynx. Future studies must show, if sentinel node detection is suitable to limit
the extent of lymph node dissection in clinically N0 necks of patients suffering from pharyngeal and laryngeal squamous cell
carcinoma.
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Paralell to other tumour entities there were intensiﬁed efforts with-
in the last two decades, which are still discussed controversially, to
limit the extent of lymph node dissection in the clinically staged
N0 situations also for head and neck cancer patients. The aim of
reducing a potential excess of surgical therapy for the patient is
currently achieved quite successfully in other tumour entities by
applying the so-called sentinel node (SN) concept (Lingam et al,
1997; De Cicco et al, 2000; Lantzsch et al, 2001). The extensive
investigations on large patient cohorts in breast cancer and malig-
nant melanoma are opposed by a comparative paucity of
experience with the SN concept for SCC of the upper aerodigestive
tract (Pitman et al, 1998; Shoaib et al, 1999, 2001; Alex et al, 2000;
Chiesa et al, 2000; Colnot et al, 2001; Stoeckli et al, 2001). Most of
these articles predominantely deal with oral cancer. Contrary to
this, it was the aim of the present study to analyse the role of
the SN procedure in patients with pharyngeal and laryngeal carci-
noma, which are the most frequent cancers of the upper
aerodigestive tract. Primary criterion for inclusion was the N0 neck
as staged by ultrasound scanning. Further inclusion criterion was
the feasibility of a transoral exposure of the tumour. Adequate
injection of the tracer substance especially in the caudal margin
of the tumour. Due to inadequate exposure of the tumour three
patients (2x larynx, 1x hypopharynx) had to be excluded from
the study.
PATIENTS AND METHODS
This study was approved by an ethics committee and written
informed consent was obtained from the patients at the beginning
of therapy.
Patients
In 50 previously untreated patients (6 female, 44 male; age range:
33–79 years, median: 63 years) suffering from squamous cell carci-
nomas of the oropharynx (n=33), the larynx (n=14) and the
hypopharynx (n=3) an intraoperative SN detection was performed.
B-mode-ultrasound assessed a N0 neck in all 50 patients. Lymph
nodes 41 cm in diameter, lymph nodes with a spherical appear-
ance or diffuse borders to the surrounding soft tissue were
deﬁned as criteria for malignancy in neck sonography. These cases
required ﬁne needle aspiration cytology and if they were preopera-
tively classiﬁed as N1-neck these cases were not enrolled in this
study. Further details on the location and TNM-classiﬁcation can
be withdrawn from Table 1.
Methods
At the beginning of the surgery (tumour resection and neck dissec-
tion) the application of a total amount of 1.2 mCi Tc99m-
nanocolloid, which was dissolved in 0.2–0.35 ml normal saline,
was performed by intraoperative injections. This amount was
chosen under the consideration of the special anatomical challenges
in the lymphatic system of the upper aerodigestive tract, which is
characterised by regional variation, but high density of lymphatics.
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www.bjcancer.comseveral neighbouring lymph node levels due to an unphysiological
increase of the interstitial pressure. Before this background, it has
to be pointed out, that more than 100 years ago Mascagni could
show, that lymphatic ﬂuids usually pass up to eight lymph nodes
until they enter the blood vessels.
The tracer substance, which had been aspirated into a 1 ml
syringe (Plastipak
1, Becton Dickinson, Madrid, Spain) was injected
into four spots at the perimeter of the tumour under microscopic
control. In cases of easily accessible SCCs of the oropharynx a hypo-
dermic 24 Gauge needle of 25 mm length (Microlance3
1, Becton
Dickinson, Drogheda, Ireland) was used. Laryngeal and hypophar-
yngeal carcinomas were exposed via rigid endoscopy in general
anaesthesia. The tracer substance was then injected under micro-
scopic control into the perimeter of the tumour, using a 23 Gauge
needle of 80 mm length (Sterican
1, B Braun, Melsungen, Germany),
ensuring that no considerable amounts of the tracer were spilled.
Based on the results of previous studies (Werner et al, 1999),
which will be summarised brieﬂy in the Discussion, preoperative
lymphoscintigraphy was not performed in this investigation. Blue
dye injection was also not used to identify the ﬁrst draining lymph
nodes.
Using a 14-mm diameter straight collimated probe (Navigator,
Gamma Guidance System, Autosuture, Toenisvorst, Germany) the
intraoperative identiﬁcation of the sentinel nodes was performed
within a maximum delay of 6 h (time range 2–6 h). This time
span which may seem extended is based on the fact that in certain
cases a bilateral neck dissection (n=20) with identiﬁcation of radi-
olabelled lymph nodes on both sides of the neck had to be
performed. Indications for bilateral neck dissection were carcino-
mas, which extended to the midline or trespassed it. With one
exception all supraglottic carcinomas (5/6) were also treated by
bilateral neck dissection. The exception to the rule was a patient
suffering from a small T2 carcinoma of the supraglottis which
was located on the free edge of the epiglottis with a wide clear
margin to the midline. The extent of neck dissection depended
on the size and likelihood of occult metastatic spread.
Subsequent intraoperative readings with the gamma probe were
performed to identify the sentinel nodes. Readings were usually
performed after elevation of the cutaneous ﬂaps. In the following,
the lymph node containing tissue of the predominant metastatic
region (usually level II or III) was mobilized, until the operation
specimen could be rotated carefully. It was necessary to increase
the distance between neck dissection specimen and primary injec-
tion site of the tracer substance to reduce the inﬂuence of
radioactive scattering on identiﬁcation of the SN with the gamma
probe. The identiﬁed hot nodes were excised and extra-corporal
control readings were performed. Due to the fact that especially
carcinomas of the upper aerodigestive tract may initially drain into
more than one lymph node, the three hottest nodes, containing
more than 10 times the background level of radioactivity, were
deﬁned as sentinel nodes (SN1-3). Unilateral (n=30) or bilateral
(n=20) neck dissection was then performed. Following uni- or
bilateral neck dissection, the primary tumour was excised either
by conventional surgery (n=3) or laser surgery (n=47), depending
on the size and location of the lesion. In the remaining eight
patients, in whom the carcinoma had been removed transorally
by laser microsurgery, the operation had been performed directly
prior to neck dissection, which facilitated intraoperative SN detec-
tion. The main cause for improved detection of the sentinel nodes
was the elimination of scattered radiation from the peritumoural
tissue. When performing this type of procedure, which is currently
favoured by us, a time space of 15–20 min passes between tracer
injection and laser microsurgical resection of the primary.
In this study the sentinel nodes as well as each lymph node of
the neck dissection specimen were divided along the equatorial
plane into two halves, which then were embedded in parafﬁn. Seri-
al sections at intervals of 1 mm were sliced resulting in complete
work-up of the entire lymph node. The sections were then stained
with H&E. One section per lymph node was stained with PAS, and
another section was stained immunhistochemically for ceratin
using the pan-cytokeratin antibody MNF 116 (Chemicon,
Hofheim, Germany).
RESULTS
In all 50 patients one or more sentinel nodes could be detected
intraoperatively. A total number of 90 sentinel nodes could be
identiﬁed. Sixteen out of ninety sentinel nodes were found on
the contralateral side in carcinomas, which were either situated
in the midline or expanded over the midline (Table 2). Corre-
sponding to the varying density of the lymphatics of the upper
aerodigestive tract, the median number of identiﬁed hot nodes
depended on the location of the primary tumour. When calculating
median values it became evident, that carcinomas of the orophar-
ynx and the supraglottis had two sentinel nodes, whereas glottic
carcinomas usually had only one ﬁrst draining lymph node.
During pathohistologic examination a total of 2538 lymph nodes
were analysed. On an average 36 lymph nodes (range 15–67) were
examined histologically per neck dissection specimen (n=70).
Forty-one out of 50 patients had tumour free sentinel nodes
reﬂecting the neck regional lymph node status (pN0), while in
seven patients a solitary macrometastasis (H&E) and in one patient
a micrometastasis (MNF 116) was proven during histopathological
examination (pN1(mi)). In the remaining patient (T2 oropharyn-
geal carcinoma) a pitfall occurred (Table 3). The intraoperatively
identiﬁed SN was shown to be tumour free during histopathologi-
cal investigation. However, a directly neighbouring lymph node
histologically proved to contain a metastasis of 0.65 cm in diameter
with perinodal spread (pN1). This lymph node had not been
suspicious on macroscopic examination. Intraoperative and extra-
corporal readings of the dissected neck dissection specimen had
shown no tracer accumulation within this lymph node. Thus there
were nine patients with nodal disease and the procedure correctly
identiﬁed eight of these (Table 4). Therefore, the sensitivity of










Table 1 Patients data
Clinically Clinically
Location T-stage N-stage M-stage
Oropharynx Soft palate 16T1 66N0 66M0
(n=33) (n=6) 36T2
26T3
Tonsil 46T1 206N0 206M0
(n=20) 96T2
76T3
Base of the tongue 46T1 76N0 76M0
(n=7) 36T2
06T3
Larynx Supraglottis 06T1 66N0 66M0
(n=14) (n=6) 56T2
16T3
Glottic 06T1 86N0 86M0
(n=8) 06T2
86T3
Hypopharynx Piriform sinus 16T1 26N0 26M0
(n=3) (n=2) 16T2
06T3
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disease was found to be 18%. The rate of micrometastases
(52 mm) with a size between 0.5–1 mm within the neck dissection
specimen was 87.5% (7/8) in cases of histologically proven macro-
metastases within the sentinel nodes (n=8) and 0% (0/41) in cases
of tumour free sentinel nodes (n=41). The number of isolated
tumour cells was 21.9% (9/41) in cases of tumourfree sentinel
nodes. In the patient with a false negative sentinel node the neck
dissection specimens (pN1) contained one further micrometastases.
DISCUSSION
The controversy on the extent of surgical therapy of the clinically
unsuspicious lymphatic drainage region of a malignant tumour
occupies all surgical specialties. With regard to this background
SN detection proved to be an accurate technique in melanoma
and breast cancer patients, in order to predict lymph node status
(Ferwerda et al, 2000; Gennari et al, 2000; Veronesi et al, 2001).
Corresponding to previously reported results in SN detection in
easily accessible SCC of the upper aerodigestive tract like oral carci-
noma (van den Brekel et al, 1999; Nieuwenhuis et al, 2000;
Margolin et al, 2001; Zitsch et al, 2000), the SN concept may also
be of signiﬁcance in pharyngeal and laryngeal cancer, which so far
have rarely been the topic of targeted investigations.
In contrast to the procedure in breast cancer we abstain from
performing a preoperative dynamic lymphoscintigraphy as well as
from additional injection of blue dye. In previous investigations
(Werner et al, 1999) it could be shown, that transcutaneous read-
ings in the area of the deep jugular lymph node level II–IV allow
no exact identiﬁcation of the sentinel nodes. Furthermore the depic-
tion of lymphatic drainage in dynamic scintigraphy was tightly
bound to the quality of the injection technique. Interferences
through a poor exposure of the tumour, sudden movements of
the patient or gagging become evident and obscured the depiction
of the lymphatic drainage into the representative main draining
level of a primary tumour. Due to the fact, that intraoperative
approach renders good exposure and precise injections because of
less interference by the patient, we exclusively prefer the intraopera-
tive injection technique even in carcinomas of the soft palate or
tonsil. In carcinomas of the deeper parts of the pharynx and larynx
the intraoperative injection technique usually is mandatory.
We abstained from blue dye injection for several reasons. An
accidental damage to the lymphatic duct may lead to extravasation
of blue dye, which might not only cause impaired overall view of









Table 2 Distribution of radiolabelled sentinel nodes
Unilateral Bilateral Total number Ipsilateral Contralateral Average of
Location neck dissection neck dissection sentinel nodes (SN) SN (n=) SN (n=) sentinel nodes (SN)
Soft palate 2 4 16one SN 8 4 2
(n=6) 46two SN
16three SN
Tonsil 12 8 56one SN 36 5 2.05
(n=20) 96two SN
66three SN
Base of the tongue 4 3 16one SN 11 2 1.86
(n=7) 36two SN
26three SN
Supraglottis 1 5 26one SN 6 4 1.66
(n=6) 46two SN
06three SN
Glottic 8 – 66one SN 10 – 1.25
(n=8) 26two SN
06three SN
Piriform sinus 1 1 16one SN 2 1 1.5
(n=2) 16two SN
06three SN




Table 4 Predictiveness of sentinel lymphonodectomy in pharyngeal and
laryngeal N0 cancer
No. of cases Post
and % N-status Location
SN predictive (49/50) 98% 416pN0 32/33 oropharynx
76pN1 14/14 larynx
16pN1(mi) 3/3 hypopharynx
False-negative (1/50) 2% 16pN1 1/33 oropharynx
Sensitivity 8/9 or 89% (95% conﬁdence interval 63–100%)
Table 3 Results of sentinel lymphonodectomy in pharyngeal and laryn-
geal N0 cancer
Histology of the
No. Histology of the neck dissection Post
Location pts. sentinel nodes specimen N-status
Oropharynx 33 606tumour free 14936tumour free 276pN0
46macrometastasis 16macrometastasis 56pN1
16micrometastasis 16pN1 (mi)
Larynx 14 186tumour free 8516tumour free 126pN0
26macrometastasis 26pN1
Hypopharynx 3 36tumour free 1046tumour free 26pN0
16macrometastasis 16pN1
No.: number; pts.: patients; ln.: lymph nodes; post N-status: histologically conﬁrmed
neck lymph node status.
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early as in the year of 1985 anaphylactic reactions after subcuta-
neous injections of blue dye had been reported (Longnecker et
al, 1985), which may be evident in 2% of the investigated cases,
as reﬂected by the current literature (Cimmino et al, 2001). With
regard to these complications and the resulting potential danger
of accidental damage to functionally relevant structures the addi-
tional application of blue dye does not seem to be justiﬁed,
especially when considering that the scintigraphy method gives
good results.
Based on the detailed analyses of the lymphatics of the human
upper aerodigestive tract (Werner, 1995a,b) it can be said, that
the direction of the lymphatic drainage of this area is relatively
constant. This was also shown for the main direction of the meta-
static spread in carcinomas of the head and neck (Lindberg,
1972). Exact knowledge of these metastatic patterns allow a targeted
mobilization of this tissue, which contains the respective lymph
nodes in the predominant region of metastatic spread of a primary.
Its rotation renders the intraoperative identiﬁcation of the radiola-
belled sentinel nodes with less interference of the scattered
radiation of the primary injection side. The recently developed strat-
egy to remove the primary tumour laser surgically prior to
performing the neck dissection has proven to be beneﬁcial with this
regard. The potential disadvantage of radiation scattering from the
primary injection site, which may impede the identiﬁcation of the
sentinel node, may thus be eliminated to the greatest possible extent.
The results, which can be achieved with this method are promis-
ing. Sentinel nodes free of disease did reﬂect the correct stage of
the regional nodal status (pN0) – with respect to the known direct
inﬂuence of the prognosis – in 41 of 50 investigated pharyngeal
and laryngeal cancer patients. At this point it should not be
omitted, that, despite a rate of 0% for micrometastases, the rate
of isolated tumour cells in the remaining neck dissection specimen
was found to be 21.9%. But it has to be pointed out, that this ﬁnd-
ing was determined throughout an advanced histopathological
examination, which does not seem to be feasible for the clinical
routine due to high costs and expenditure of labour. The status
of such an advanced work-up of the neck dissection specimen
can not be estimated at present. We would like to agree with
Hermanek (1999), who proposed that the introduction of an
advanced examination of lymph nodes regarding isolated or disse-
minated tumour cells ﬁrst of all requires standardization of the
procedure and description of the clinical relevance. It seems to
be out of the question, that an additional reference to isolated
tumour cells (sufﬁx: i) or micrometastasis (sufﬁx: mi) would be
desirable in a histopathologic report, as it was recommended by
the UICC 1999. However, as long as the independent prognostic
signiﬁcance of isolated tumour cells is still unclear, it is not going
to be considered in the further discussion.
The detection of solitary macrometastasis (pN1) in seven
patients and of a micrometastasis (pN1(mi)) in one patient with
clinically staged N0 neck seemed to be very interesting. The
detailed investigation of each lymph node of the neck dissection
specimen revealed in 7/8 patients 1–2 further micrometastases
within the lymph nodes of the neck dissection specimen. Among
41 patients without macrometastases were 0/41 patients suffering
from micrometastases and 9/41 patients in whom isolated tumour
cells could be detected. Thus, the rate of occult metastatic spread in
the presented investigation was 18% for nodal disease, which is in
accordance with the literature for SCC of the head and neck (Hosal
et al, 2000). With regard to these results radiolabelled SN detection
showed a sensitivity of 89%. These ﬁndings suggest that the SN
method renders detection of lymphogenic metastatic spread also
in patients with carcinomas of the pharynx and larynx.
This statement is of relevance especially for T3 glottic carcino-
mas. Glottic carcinomas, which are sometimes staged by the
pathologist as T2 tumours, or rarely even as T3 tumours because
of ﬁxed vocal cords. This is an excellent example for the necessity
of interdisciplinary communication in ﬁnding the correct diagno-
sis. Resection of the previously mentioned T3 glottic tumours
may be possible for especially trained surgeons by laser micro
surgery in selected cases. Provided that good exposure of the
tumour is given as inclusion criterion for laser micro surgery, a
targeted peritumoural injection of the tracer substance poses no
difﬁcult problem for laser surgically trained surgeons. It should
not be omitted to point out, that the tracer injection may be difﬁ-
cult at the caudal margin.
If this technique does not seem to be feasible, we would
consider the procedure risky, if the caudal margin cannot be
injected transtumourally under endoscopic control with the
required reliability. This could be shown in three patients (2x
larynx, 1x hypopharynx) which we not included in the present
study for obvious reasons. For these situations we actually devel-
oped an injection via a butterﬂy cannula (Winged infusion set,
23G, 0.65620 mm, Braun, Melsungen, Germany), which can be
inserted in an oblique angle.
Some surgeons perform a selective neck dissection in T3 glottic
carcinomas because of the important inﬂuence of lymphogenic
metastatic spread on prognosis of patients with carcinomas of
the head and neck, although the likelihood of occult lymphogenic
metastatic spread in T3 glottic carcinoma is only estimated to be
10–15% (Sinard et al, 1996). The critical analysis of further multi-
centric trials reporting on SN detection in T3 glottic carcinomas
may lead to a more precise estimation of the risk of occult meta-
static spread and thus eventually to a more limited surgical
approach in this special indication.
Despite of the encouraging results we would like to point out,
that perinodal spread may be a reason for non-accumulation of
a tracer substance, which has been reported previously (Borgstein
et al, 1998). The phenomenon of perinodal spread, which is usually
seen in advanced metastatic spread, may also be evident in smaller
metastases (Croce et al, 1992; Coatesworth and MacLennan, 2002),
as could also be shown in one of our patients. The head and neck
surgeon has to be aware of this fact, when performing and inter-
preting the results of SN detection in head and neck cancer.
In summary, although we have shown, that skipping of nodal
basin can occur, this technique still reliably identiﬁes the sentinel
nodes in pharyngeal and laryngeal cancer. Usually this applies to
laryngeal and supraglottic T1-T2 carcinomas as well as T3 glottic
carcinoma. The limiting factor of the feasibility of this technique
seems to be the reliable caudal margin of the tumour.
In conclusion it has to be assumed, that SN detection in carci-
nomas of the upper aerodigestive tract is ﬁrst of all a diagnostic
procedure. Through a targeted histopathological examination in
serial sections the radiolabelled sentinel nodes may help to increase
the diagnostic reliability of a limited neck dissection. This may help
in decision making, whether more radical surgery is required,
whether postoperative radio(chemo)therapy is necessary or whether
a wait and see policy is justiﬁed.
The radioguided dissection of the 2–3 hottest nodes and the
surrounding tissue may be a further step in reduction of radicality
in surgery of the clinically staged N0 neck. However, the value of
such an approach has to be examined in multicentric trials. As
future perspective it may be possible to direct the efforts on a
development of an endoscopic neck dissection (Carreno et al,
1999; Dulguerov et al, 2001), which would then be performed as
a very limited form of neck dissection. Preliminary own experi-
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